Document is current
Any future updates will be listed below
-
Authors
Adnan Awad, Shady https://orcid.org/0000-0001-6205-7799
Dufva, Olli https://orcid.org/0000-0002-8084-0282
Ianevski, Aleksandr
Ghimire, Bishwa https://orcid.org/0000-0001-5076-8366
Koski, Jan https://orcid.org/0000-0002-6788-2760
Maliniemi, Pilvi
Thomson, Daniel
Schreiber, Andreas
Heckman, Caroline A.
Koskenvesa, Perttu
Korhonen, Matti https://orcid.org/0000-0002-1573-0458
Porkka, Kimmo
Branford, Susan
Aittokallio, Tero https://orcid.org/0000-0002-0886-9769
Kankainen, Matti https://orcid.org/0000-0002-4714-9481
Mustjoki, Satu https://orcid.org/0000-0002-0816-8241
- License Information
-
More Information
Article History
Received: 16 May 2020
Revised: 26 July 2020
Accepted: 29 July 2020
First Online: 11 August 2020
Compliance with ethical standards
:
: SM has received honoraria and research funding from Novartis, Pfizer and Bristol-Myers Squibb (not related to this study). SAA has received research funding from Incyte. SB is a member of Member of the advisory board of Qiagen, Novartis, and Cepheid and has received research funding from Novartis, honoraria from Novartis, Qiagen, Cepheid, and Bristol-Myers Squibb and support from the National Health and Medical Research Council of Australia APP1117718 and APP1104425, the Ray and Shirl Norman Cancer Research Trust, and the Royal Adelaide Hospital Research Foundation. The other authors declare that they have no conflict of interest.
